CA2331871A1 - Novel formulation containing paroxetine - Google Patents
Novel formulation containing paroxetine Download PDFInfo
- Publication number
- CA2331871A1 CA2331871A1 CA002331871A CA2331871A CA2331871A1 CA 2331871 A1 CA2331871 A1 CA 2331871A1 CA 002331871 A CA002331871 A CA 002331871A CA 2331871 A CA2331871 A CA 2331871A CA 2331871 A1 CA2331871 A1 CA 2331871A1
- Authority
- CA
- Canada
- Prior art keywords
- paroxetine
- anhydrous
- tablets
- hemihydrate
- paroxetine hydrochloride
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9810181.9A GB9810181D0 (en) | 1998-05-13 | 1998-05-13 | Novel formulations |
| GB9810181.9 | 1998-05-13 | ||
| PCT/GB1999/001520 WO1999058113A2 (en) | 1998-05-13 | 1999-05-13 | Novel formulation containing paroxetine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2331871A1 true CA2331871A1 (en) | 1999-11-18 |
Family
ID=10831927
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002331871A Abandoned CA2331871A1 (en) | 1998-05-13 | 1999-05-13 | Novel formulation containing paroxetine |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP1077682A2 (de) |
| JP (1) | JP2002514591A (de) |
| KR (1) | KR20010043574A (de) |
| CN (1) | CN1308521A (de) |
| AP (1) | AP2000002019A0 (de) |
| AU (1) | AU3940999A (de) |
| BG (1) | BG105010A (de) |
| BR (1) | BR9910401A (de) |
| CA (1) | CA2331871A1 (de) |
| EA (1) | EA200001174A1 (de) |
| GB (1) | GB9810181D0 (de) |
| HU (1) | HUP0102064A2 (de) |
| ID (1) | ID28019A (de) |
| IL (1) | IL139594A0 (de) |
| NO (1) | NO20005683L (de) |
| PL (1) | PL344573A1 (de) |
| SK (1) | SK17142000A3 (de) |
| TR (1) | TR200003350T2 (de) |
| WO (1) | WO1999058113A2 (de) |
| ZA (1) | ZA200006562B (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0003232D0 (en) * | 2000-02-11 | 2000-04-05 | Smithkline Beecham Plc | Novel composition |
| CA2359812C (en) | 2000-11-20 | 2004-02-10 | The Procter & Gamble Company | Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures |
| AU2002330771A1 (en) * | 2001-10-22 | 2003-06-10 | Synthon B.V. | N-formyl derivatives of paroxetine |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9325644D0 (en) * | 1993-12-15 | 1994-02-16 | Smithkline Beecham Plc | Novel formulation |
| US5672612A (en) * | 1996-09-09 | 1997-09-30 | Pentech Pharmaceuticals, Inc. | Amorphous paroxetine composition |
| EA002034B1 (ru) * | 1997-01-15 | 2001-12-24 | Смитклайн Бичам Плс | Композиция на основе пароксетина |
| BR9813808A (pt) * | 1997-12-19 | 2002-05-28 | Smithkline Beecham Corp | Processo para produção de comprimidos para dispersão na mordida |
-
1998
- 1998-05-13 GB GBGB9810181.9A patent/GB9810181D0/en not_active Ceased
-
1999
- 1999-05-13 HU HU0102064A patent/HUP0102064A2/hu unknown
- 1999-05-13 CA CA002331871A patent/CA2331871A1/en not_active Abandoned
- 1999-05-13 EA EA200001174A patent/EA200001174A1/ru unknown
- 1999-05-13 CN CN99808325A patent/CN1308521A/zh active Pending
- 1999-05-13 JP JP2000547965A patent/JP2002514591A/ja active Pending
- 1999-05-13 AU AU39409/99A patent/AU3940999A/en not_active Abandoned
- 1999-05-13 ID IDW20002347A patent/ID28019A/id unknown
- 1999-05-13 EP EP99922302A patent/EP1077682A2/de not_active Withdrawn
- 1999-05-13 KR KR1020007012706A patent/KR20010043574A/ko not_active Application Discontinuation
- 1999-05-13 PL PL99344573A patent/PL344573A1/xx unknown
- 1999-05-13 TR TR2000/03350T patent/TR200003350T2/xx unknown
- 1999-05-13 SK SK1714-2000A patent/SK17142000A3/sk unknown
- 1999-05-13 BR BR9910401-6A patent/BR9910401A/pt not_active Application Discontinuation
- 1999-05-13 WO PCT/GB1999/001520 patent/WO1999058113A2/en not_active Application Discontinuation
- 1999-05-13 IL IL13959499A patent/IL139594A0/xx unknown
- 1999-05-13 AP APAP/P/2000/002019A patent/AP2000002019A0/en unknown
-
2000
- 2000-11-10 NO NO20005683A patent/NO20005683L/no not_active Application Discontinuation
- 2000-11-13 ZA ZA200006562A patent/ZA200006562B/en unknown
- 2000-11-30 BG BG105010A patent/BG105010A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA200006562B (en) | 2002-02-13 |
| GB9810181D0 (en) | 1998-07-08 |
| HUP0102064A2 (hu) | 2002-05-29 |
| ID28019A (id) | 2001-05-03 |
| WO1999058113A3 (en) | 2000-02-17 |
| NO20005683D0 (no) | 2000-11-10 |
| TR200003350T2 (tr) | 2001-03-21 |
| AP2000002019A0 (en) | 2000-12-31 |
| AU3940999A (en) | 1999-11-29 |
| BR9910401A (pt) | 2001-01-09 |
| WO1999058113A2 (en) | 1999-11-18 |
| NO20005683L (no) | 2000-12-05 |
| PL344573A1 (en) | 2001-11-05 |
| EP1077682A2 (de) | 2001-02-28 |
| SK17142000A3 (sk) | 2001-06-11 |
| EA200001174A1 (ru) | 2001-06-25 |
| IL139594A0 (en) | 2002-02-10 |
| CN1308521A (zh) | 2001-08-15 |
| BG105010A (en) | 2001-07-31 |
| KR20010043574A (ko) | 2001-05-25 |
| JP2002514591A (ja) | 2002-05-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0503440B1 (de) | Sumatriptan enthaltende Arzneimittel | |
| US9340307B2 (en) | Stable laquinimod preparations | |
| US4929605A (en) | Pharmaceutical composition for piperidinoalkanol derivatives | |
| US6100274A (en) | 8-chloro-6,11-dihydro-11- ](4-piperidylidine)-5H-benzo[5,6]cyclohepta[1,2-bpyridine oral compositions | |
| CZ292069B6 (cs) | Farmaceutický přípravek zahrnující moxifloxacin, způsob výroby a použití tohoto přípravku | |
| CA2325014C (en) | 8-chloro-6,11-dihydro-11-(4-piperidylidene)-5h-benzo[5,6]cyclohepta[1,2-b]pyridine oral compositions | |
| CA2331871A1 (en) | Novel formulation containing paroxetine | |
| CA2255064C (en) | Potassium, sodium and tris oxaprozin salt pharmaceutical formulations | |
| US20030153617A1 (en) | Simvastatin dosage forms | |
| CA2304594A1 (en) | Amorphous paroxetine composition | |
| CA2399411A1 (en) | Water dispersible formulation of paroxetine | |
| EP2101742A2 (de) | Clopidogrel-hydrogensulfat von polymorph 1 form enthaltende pharmazeutische zusammensetzung | |
| ZA200006465B (en) | Novel formulation containing paroxetine. | |
| MXPA00011154A (en) | Novel formulation containing paroxetine | |
| CZ20004186A3 (cs) | Nový prostředek obsahující paroxetin | |
| JP4824224B2 (ja) | 糖衣製剤 | |
| CA2367402C (en) | Stable pharmaceutical dosage form for paroxetine anhydrate | |
| NZ270729A (en) | Fluvastatin sodium in an alkaline carrier | |
| KR20030070594A (ko) | 암로디핀 말레에이트를 포함하는 약학 조성물 | |
| CZ20004185A3 (cs) | Nový prostředek obsahující paroxetin |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Discontinued |